No Detail Found!

Neuroprotectıve potential of the tubers of corydalis triternata Zucc. growing in Turkey

Author(s)
Mehtap Kılıc Department of Pharmacognosy, Faculty of Pharmacy, Gazi University, 06330 Ankara, Turkey.
Erdal Kaya Department of Ornamental Plant Breeding and Agronomy, Atatürk Horticultural Central Research Institute, 77102 Yalova.
Ayhan Ibrahim Aysal Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Gazi University, 06330 Ankara, Turkey.
Bilge Sener Department of Pharmacognosy, Faculty of Pharmacy, Gazi University, 06330 Ankara, Turkey.
Abstract
The continuing research for the determination of bioactive secondary metabolites from Turkish geophytes as therapeutic agents for dementia is mainly based on the need for drug candidates affected to brain areas. In this study, the in vitro anticholinesterase activity of the alkaloidal fractions of the tubers of Corydalis triternata Zucc. was investigated for their neuroprotective potential. Furthermore, the content of the active alkaloid fractions of the tubers was determined by LC-Q-TOF-MS. The tubers of Corydalis triternata Zucc. were collected from Hatay province of Turkey. The plant species were also preserved as ex-situ in Yalova-Turkey. The alkaloidal extract was prepared from the tubers. The anticholinesterase activities of the extracts and fractions were tested by modification of the Ellman's method. The optimization of LC-MS conditions was used in ESI in the positive ion mode. The in vitro tests were highlighted that the alkaloidal extract of the tubers exhibited the highest activity against AChE and BuChE with IC50 values of 17.56 ± 1.0 mg/mL and 326.23 ± 2.6 mg /mL (galanthamine 6.8 ± 0.5 mg /mL and 344.4 ± 8.2 mg /mL as positive control), respectively. The fractions CK-3 and 4 were showed the highest inhibitory activity against AChE with the IC50 value (6.88 ± 0.3 mg mL and 7.26 ± 0.3 mg /mL), the fractions CK-5,6,7 and 8 have indicated potent inhibitory activities by compared with galanthamine, which was used as positive control with IC50 value 6.8 ± 0.5 mg /mL. Among the fractions obtained from the alkaloidal extract, protoberberine-type alkaloids were exerted the most promising activity against both cholinesterases. The present study was described for the first time the in vitro anticholinesterase activity of Corydalis triternata Zucc. as neuroprotective potential and their metabolite profile by LC-Q-TOF-MS. Besides, the anticholinesterase assays on alkaloidal extract and its fractions showed that protoberberine-type alkaloids were determined the most potent inhibitor against AChE and BuChE.
Publication Details
Page(s) 515-524
Published Journal: Journal of Chemical Society of Pakistan, Volume: 42, Issue: 4, Year: 2020

Request the full text from PASTIC

Keywords
Anticholinesterase, Alkaloids, Corydalis triternata Zucc, isoquinolines
References
M.P. Mattson .2004 .Pathways towards and away from Alzheimer's disease. Nature, 430 : 631.
P.J. Houghton M.J.,Howes M.J. .2005 .Natural products and derivatives affecting neurotransmission relevant to Alzheimer's and Parkinson's disease. Neurosignals, 14(6) : .
Wimo A.,Winblad B.,Aguero-Torres H.,E. von Strauss H. .2003 .The magnitude of dementia occurrence in the World, Alzheimer Dis. , 17(63) : .
Sener .2010 .tyrosinase inhibition studies and antioxidant activities of 33 Scutellaria L. taxa from Turkey, Food Chem. , 48(781) : .
Eckert G.P. .2010 .Traditional used plants against cognitive decline and Alzheimer's disease. Front Pharmacol, 00138 : .
Thomsen T.,Zendeh B.,Fischer J.P.,Kewitz H. .1991 .In vitro neffects of various cholinesterase inhibitors on acetyl- and butyrylcholinesterase of healthy volunteers, Biochem. , 41(1391) : .
Barz G. .1991 .Gusztony, Inhibition of acetylcholinesterase activity in human brain tissue and erythrocytes by galanthamine, physostigmine and tacrine. Eur. J. Clin. Biochem, 29(487) : .
Bores G.M.,Huger F.P.,Petko W.,Mutlib A.E.,Camacho F.,Rush D.K. .1996 .Pharmacological evaluation of novel Alzheimer's disease therapeutics: acetylcholinesterase inhibitors related to galanthamine. , 277(728) : .
Heinrich M.,Teoh H.L. .2004 .Galanthamine from snowdrop - the development of a modern drug against Alzheimer's disease from local Caucasian knowledge. , 92(147) : .
A.E. Adewusi N.,Moodley V.,Steenkamp V. .2010 .Medicinal plants with cholinesterase inhibitory activity: a review, Afr. , 9(8257) : .
Guner A.,Aslan S.,Ekim T.,Vural M. .2012 .. Nezahat Gökyiğit Botanik Bahçesi ve Flora Araştırmaları Derneği, 660 : .
Orhan I.E.,Khan M.T.H.,Erdem S.A.,Kartal M.,Sener B. .2011 .Selective cholinesterase inhibitors from Buxus sempervirens L. and their molecular docking studies. Curr.Comp.-Aided Drug Design, 7(276) : .
H.O. Gulcan I. Erdogan,Orhan B.,Sener B. .2015 .Chemical and Molecular Aspects on Interactions of Galanthamine and Its Derivatives with Cholinesterases, Curr. , 16(252) : .
Ellman G.I.,Courtney D.,Andres V.,Featherstone R.M. .1961 .A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol., 7(88) : .
Scudiere D.A.,Shoemaker R.H.,Paul K.D.,Monks A.,Tierney S.,Nofziger T.H.,Currens M.J.,Seniff D.,Boyd M.R. .1998 .Evaluation of a souble tetrazolium/formazan assay for cell growth and drug sensitivty in culture using human and other tumor cell lines. Cancer Res., 48(4827) : .
Sener B. .1986 .Mass spectra of some isoquinoline alkaloids. , 108 : .
Mingqian S.,Jianxun L.,Chengren L.,Lan M.,Li L. .2014 .Alkaloid profiling of the traditional Chinese medicine Rhizoma Corydalis using high performance liquid chromatography-tandem quadrupole time-of-flight massspectrometry. Acta Pharmaceut. Sinica B, 208(3) : .
Z.-X. Qing Z.-X.,Peng P.,Yang Q.,Tang Q.,-B. Liu Y.-J.,Zheng Y.-J. .2017 .Isoquinoline alkaloids and their antiviral, antibacterial and antifungal activities and structure-activity relationship. Current Org. Chem, 21(15) : .
0

Citations

0

Downloads

15

Views